Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    9400508 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
Condition: Sarcoma, Synovial
Interventions: Drug: OTSA101-DTPA-90Y level 1;   Drug: OTSA101-DTPA-90Y level 2;   Drug: OTSA101-DTPA-90Y level 3
2 Completed Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure
Condition: Soft Tissue Sarcoma
Intervention: Drug: LBH589 (Panobinostat®)

Study has passed its completion date and status has not been verified in more than two years.